Back to PPM Roll-Ups
Legal / Service Provider·PPM Roll-Ups

Maureen Ladouceur

Operating Partner, Healthcare Team at Welsh, Carson, Anderson & Stowe

Greater Philadelphia, PA

ML
LinkedIn
Why they matter

Now EnableComp's CCO after leaving WCAS in mid-2026, she brings rare RCM and payor commercial-scaling expertise from growing Norstella's revenue 30x.

Background

Maureen Ladouceur is a healthcare and life sciences commercial executive who began her career as a clinical registered nurse at Thomas Jefferson University Hospital before moving into commercial leadership roles at McKesson, Vocollect Healthcare Systems, and Quantia. She spent roughly a decade at MMIT/Norstella, rising to President and Global Chief Commercial Officer and growing revenue more than 30x through organic growth and integration of acquisitions including Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group. She joined Welsh, Carson, Anderson & Stowe as an Operating Partner on the Healthcare Team in September 2025, then departed to become Chief Commercial Officer at EnableComp in June 2026.

Notable deals

  • 2025
    As EVP & Global Chief Commercial Officer / President of Norstella, grew commercial revenue more than 30x over a decade through organic growth and integration of multiple acquisitions
  • 2025
    Appointed Operating Partner on the Healthcare Team at Welsh, Carson, Anderson & Stowe, focused on commercial excellence across the healthcare portfolio
  • 2026
    Named Chief Commercial Officer of EnableComp, leading the commercial organization for complex healthcare revenue-cycle management claims

Call-prep brief

Background

  • Started as a clinical RN at Thomas Jefferson University Hospital, then moved through commercial roles at McKesson, Vocollect Healthcare Systems, and Quantia.
  • Spent roughly a decade at MMIT/Norstella (CRO → CCO → EVP & Global CCO/President), growing revenue 30x+ via organic growth and integrating five-plus acquisitions.
  • BSN (Pitt), MBA (Penn State), business strategy certificate (Cornell).

Current focus

  • CCO at EnableComp (since June 2026), leading commercial strategy for complex healthcare revenue-cycle management (RCM).
  • Prior to that: Operating Partner, Healthcare Team at Welsh, Carson, Anderson & Stowe (Sept 2025–mid-2026) — a brief, ~9-month tenure.

What she cares about

  • Translating clinical empathy (her nursing background) into commercial relationship-building.
  • Scaling multi-business commercial organizations through M&A integration.
  • Patient access to therapy across payor, provider, and life-sciences segments.

Sensitivities

  • She is no longer at WCAS — outreach framed as "WCAS Operating Partner" is stale; approach her as an independent commercial-scaling expert, not a WCAS resource.
  • Understand why the operating-partner seat was short-lived before assuming she wants portfolio-wide advisory work again.
  • A previously reported AssistRx board seat could not be independently confirmed via public sources — verify directly before referencing it.

Questions to ask

  1. What made the full-time CCO seat at EnableComp a better fit than the WCAS operating-partner model, and what does that suggest about structuring operating talent at PE-backed healthcare platforms?
  2. Which specific commercial-integration playbooks from the Norstella/MMIT roll-up would translate to physician practice consolidation?
  3. Given her current RCM focus, what commercial or billing pitfalls should a physician-practice rollup diligence before close?

Outreach draft

Subject
Commercial Scaling Insights for Physician Practice Rollups
Hi Maureen — I'm [Placeholder Name], working with a deal team evaluating physician practice management rollups in healthcare services. Your run scaling commercial organizations from MMIT through Norstella (30x revenue growth via multiple acquisitions), plus your stint as an Operating Partner at Welsh, Carson, Anderson & Stowe, give you a rare dual lens on PE-backed healthcare platforms and hands-on commercial execution. We're trying to understand how strong operators structure commercial and RCM functions post-acquisition, and where practice rollups typically stumble on integration. Would you have 20 minutes for a call in the next couple of weeks? Happy to work around your schedule at EnableComp.

Linked companies

Sources